Great Point Partners’s Ocular Therapeutix OCUL Stock Holding History

Great Point Partners’s Portfolio OCUL Stock Details OCUL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$15.7M	Buy
2023 Q4	$3.12M	Buy
2021 Q3	–	Sell
2021 Q2	$13M	Sell
2021 Q1	$16.5M	Buy
2020 Q4	$17.7M	Buy